N
immune cell infiltration
long noncoding RNAs
m6A RNA methylation regulators
tumor microenvironment
uveal melanoma
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2021
2021
Historique:
received:
03
05
2021
accepted:
14
07
2021
entrez:
16
8
2021
pubmed:
17
8
2021
medline:
17
8
2021
Statut:
epublish
Résumé
Uveal melanoma (UM) is one of the most common malignant intraocular tumors in adults. Few studies have investigated the effect of N
Identifiants
pubmed: 34395276
doi: 10.3389/fonc.2021.704543
pmc: PMC8362329
doi:
Types de publication
Journal Article
Langues
eng
Pagination
704543Informations de copyright
Copyright © 2021 Liu, Li, Huang, Wang and Liu.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Cancer. 2005 Mar 1;103(5):1000-7
pubmed: 15651058
Invest Ophthalmol Vis Sci. 2001 Jun;42(7):1414-21
pubmed: 11381040
Blood. 2004 Dec 1;104(12):3697-704
pubmed: 15292061
Aging (Albany NY). 2019 Sep 4;11(17):6657-6673
pubmed: 31484163
Nat Commun. 2020 Jan 24;11(1):496
pubmed: 31980621
Tumour Biol. 2016 Oct;37(10):13533-13543
pubmed: 27468714
Invest Ophthalmol Vis Sci. 2003 Nov;44(11):4651-9
pubmed: 14578381
Biochim Biophys Acta. 2016 Mar;1863(3):471-482
pubmed: 26554850
Acc Chem Res. 2011 Dec 20;44(12):1380-8
pubmed: 21615108
Mol Ther. 2018 May 2;26(5):1287-1298
pubmed: 29606502
Ocul Immunol Inflamm. 2010 Apr;18(2):80-90
pubmed: 20370332
Immunol Rev. 2015 Mar;264(1):154-66
pubmed: 25703558
Mol Ther. 2017 May 3;25(5):1209-1221
pubmed: 28330694
Lancet Oncol. 2015 Apr;16(4):375-84
pubmed: 25795410
Curr Opin Immunol. 2016 Apr;39:90-5
pubmed: 26829458
Cell Res. 2018 Jun;28(6):616-624
pubmed: 29789545
Nat Commun. 2019 Oct 16;10(1):4695
pubmed: 31619685
Genomics Proteomics Bioinformatics. 2013 Feb;11(1):8-17
pubmed: 23453015
RNA Biol. 2013 Jun;10(6):915-8
pubmed: 23619745
J Immunol. 2012 Jun 1;188(11):5408-20
pubmed: 22551552
Mol Cancer. 2019 Nov 14;18(1):161
pubmed: 31722709
Mol Cell. 2018 Oct 4;72(1):71-83.e7
pubmed: 30220561
Cancer Lett. 2017 Nov 1;408:112-120
pubmed: 28867248
FEBS Lett. 2016 Jun;590(12):1729-38
pubmed: 27214741
Cell Res. 2014 Feb;24(2):177-89
pubmed: 24407421
J Biol Chem. 2018 Sep 7;293(36):14022-14039
pubmed: 30018141
Nucleic Acids Res. 2021 Jan 8;49(D1):D1420-D1430
pubmed: 33179754
Cancer Cell. 2020 Dec 14;38(6):857-871.e7
pubmed: 33125861
Biomed Pharmacother. 2019 Apr;112:108613
pubmed: 30784918
Eye (Lond). 2017 Feb;31(2):241-257
pubmed: 27911450
J Cereb Blood Flow Metab. 2020 Dec;40(12):2331-2349
pubmed: 32967524
Invest Ophthalmol Vis Sci. 2019 Nov 1;60(14):4904-4914
pubmed: 31770435
Mol Cancer. 2019 May 29;18(1):103
pubmed: 31142332
J Innate Immun. 2012;4(5-6):454-62
pubmed: 22302072
Blood Cancer J. 2013 Sep 06;3:e139
pubmed: 24013661
Nat Cell Biol. 2018 Mar;20(3):285-295
pubmed: 29476152
Cell. 2009 Feb 20;136(4):629-41
pubmed: 19239885
Biochim Biophys Acta. 2014 Nov;1839(11):1097-109
pubmed: 25159663
J Cell Physiol. 2020 Oct;235(10):7107-7119
pubmed: 32017066
Mol Cancer. 2019 Oct 13;18(1):142
pubmed: 31607270
Ophthalmology. 2011 Sep;118(9):1881-5
pubmed: 21704381
Nature. 2017 Aug 17;548(7667):338-342
pubmed: 28792938
Annu Rev Cell Dev Biol. 2017 Oct 6;33:319-342
pubmed: 28759256
Breast Cancer Res. 2016 Aug 11;18(1):84
pubmed: 27515302